DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Ratnamani Metals & Tubes Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·7 Oct 2026, 6:33 am

Ratnamani MET & TUB

Ratnamani Metals & Tubes Limited has informed stock exchanges that it has obtained a Certificate of Compliance under SEBI's Depositories and Participants Regulations, 2018. This regulatory document confirms that the company has fulfilled all necessary requirements for its dematerialized shareholding process.

For investors, this update is largely procedural. It validates the company's adherence to regulatory standards, which helps maintain transparency in the shareholding structure. While it does not signal a major corporate event, it ensures the smooth settlement of shares for shareholders holding dematerialized (demat) securities.

Moving forward, investors should monitor the company's regular financial disclosures. This certificate is a routine administrative step, so it is not expected to impact the stock's price performance directly. However, it reinforces the company's commitment to regulatory compliance.